LAE001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LAE001, covering 2024-10-10 to 2025-09-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study on the Safety and Efficacy of LAE001 in the Treatment of Metastatic Prostate Cancer [Phase 1, Phase 2]